Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Cancer Research

• Publication date

  2012-10-15

• Fields of study

  Biology, Medicine, Engineering, Environmental Science

• Identifiers
  DOI 10.1158/1078-0432.CCR-12-0858PMID 23071360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo

  2012cited by this paper
• The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function

  2012cited by this paper
• Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)

  2012cited by this paper
• Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.

  2012cited by this paper
• The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma

  2012cited by this paper
• Transient Alteration of Cellular Redox Buffering before Irradiation Triggers Apoptosis in Head and Neck Carcinoma Stem and Non-Stem Cells

  2011cited by this paper
• Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors

  2011cited by this paper
• Radiosensitization by celastrol is mediated by modification of antioxidant thiol molecules.

  2011cited by this paper
• Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis.

  2011cited by this paper
• Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation.

  2011cited by this paper
• A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor

  2011cited by this paper
• Transketolase-Like 1 Expression Is Modulated during Colorectal Cancer Progression and Metastasis Formation

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Lactate: a metabolic key player in cancer.

  2011cited by this paper
• Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release.

  2011cited by this paper
• Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

  2010cited by this paper
• Glycolytic metabolism and tumour response to fractionated irradiation.

  2010cited by this paper
• Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

  2010cited by this paper
• Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis

  2010cited by this paper
• HIF-1: upstream and downstream of cancer metabolism.

  2010cited by this paper
• Targeting metabolic transformation for cancer therapy

  2010cited by this paper
• Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.

  2010cited by this paper
• Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited.

  2010cited by this paper
• TKTL1 Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabilization

  2010cited by this paper
• Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

  2009cited by this paper
• The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects

  2009cited by this paper
• Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress

  2009cited by this paper
• Transketolase‐like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells

  2009cited by this paper
• Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Basic Clinical Radiobiology

  2009cited by this paper
• Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells

  2009cited by this paper
• Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.

  2009cited by this paper
• Considering the role of pyruvate in tumor cells during hypoxia.

  2009cited by this paper
• Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.

  2009cited by this paper
• The oxygen effect and fractionated radiotherapy

  2009cited by this paper
• The anti-oxidant capacity of tumour glycolysis

  2009influential reference
• The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors*

  2009cited by this paper
• Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

  2009influential reference
• Regulation of cancer cell metabolism by hypoxia-inducible factor 1.

  2009cited by this paper
• Uterine DCs are essential for pregnancy.

  2008cited by this paper
• 2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer.

  2008influential reference
• Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.

  2008cited by this paper
• Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.

  2008cited by this paper
• A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α

  2008cited by this paper
• Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage

  2008cited by this paper
• Causes and Consequences of Increased Glucose Metabolism of Cancers

  2008cited by this paper
• Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1α

  2008cited by this paper
• Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.

  2008cited by this paper
• Hypoxia inducible factor (HIF1α and HIF2α) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy

  2008cited by this paper
• Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells*

  2008cited by this paper
• Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer.

  2008cited by this paper
• Prognostic Impact of HIF-1α Expression in Patients with Definitive Radiotherapy for Cervical Cancer

  2008cited by this paper
• Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

  2008cited by this paper
• Molecular aspects of tumour hypoxia

  2008cited by this paper
• Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

  2008cited by this paper
• Tumor metabolism: cancer cells give and take lactate.

  2008cited by this paper
• Regulation of HIF-1alpha stability through S-nitrosylation.

  2007cited by this paper
• Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy

  2007cited by this paper
• Influence of tumor cell and stroma sensitivity on tumor response to radiation.

  2007cited by this paper
• Inhibitory effect of tumor cell-derived lactic acid on human T cells.

  2007cited by this paper
• YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia

  2007cited by this paper
• YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.

  2007cited by this paper
• The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments.

  2007cited by this paper
• Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.

  2007cited by this paper
• Regulation of HIF-1α Stability through S-nitrosylation

  2007cited by this paper
• Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

  2007cited by this paper
• Combining radiotherapy with AZD2171, a potent inhibitor of vascular endothelial growth factor signaling: pathophysiologic effects and therapeutic benefit

  2007cited by this paper
• Hypoxia signalling controls metabolic demand.

  2007cited by this paper
• Hypoxic radiosensitization: adored and ignored.

  2007cited by this paper
• Tumor cell radiosensitivity is a major determinant of tumor response to radiation.

  2006cited by this paper
• A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent.

  2006cited by this paper
• Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice.

  2006cited by this paper
• A domain responsible for HIF-1α degradation by YC-1, a novel anticancer agent

  2006cited by this paper
• RADIOTHERAPY: AN IN VITRO STUDY

  2006cited by this paper
• HIF-1 and tumour radiosensitivity

  2006cited by this paper
• Optimizing Cancer Radiotherapy with 2-Deoxy-D-Glucose

  2005cited by this paper
• Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.

  2005cited by this paper
• Engaging the vascular component of the tumor response.

  2005cited by this paper
• Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.

  2005cited by this paper
• Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions

  2004cited by this paper
• Oxidative stress, redox, and the tumor microenvironment.

  2004cited by this paper
• Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1

  2004cited by this paper
• Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

  2004cited by this paper
• Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?

  2003cited by this paper
• 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism.

  2003cited by this paper
• Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis

  2003cited by this paper
• YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

  2003cited by this paper
• Stress granules: sites of mRNA triage that regulate mRNA stability and translatability.

  2002cited by this paper
• Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation

  2002cited by this paper
• Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis*

  2002influential reference
• Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer.

  2001cited by this paper
• Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

  2001cited by this paper
• Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

  2001cited by this paper
• Free radical scavenging and antioxidant effects of lactate ion: an in vitro study.

  2000cited by this paper
• Changes in Blood Perfusion and Hypoxia after Irradiation of a Human Squamous Cell Carcinoma Xenograft Tumor Line

  2000cited by this paper
• High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.

  2000cited by this paper
• Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation

  1999cited by this paper
• Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

  1999cited by this paper
• Focus

  1985cited by this paper

• Advance of different strategies to achieve radiosensitivity based on nanomaterials

  2026cites this paper
• Mechanisms Underlying Radioresistance and Reversal Strategies in Non-Small Cell Lung Cancer

  2025cites this paper
• Application of metal-organic framework-based reactive oxygen species therapy in cancer.

  2025cites this paper
• A Nanoradiosensitizer Potentiates Tumor Radiotherapy through JFK Inhibition and Hypoxia Alleviation.

  2025cites this paper
• Research progress on the therapeutic effects of effective components of traditional Chinese medicine in the treatment of gastric cancer precursors through modulation of multiple signaling pathways

  2025cites this paper
• Minibeam radiation therapy remodels tumor microenvironment and suppresses HIF-1α/VEGFR axis to overcome radioresistance in triple-negative breast cancer

  2025cites this paper
• Optical imaging provides flow-cytometry–like single-cell level analysis of HIF-1α-mediated metabolic changes in radioresistant head and neck squamous carcinoma cells

  2025cites this paper
• D-mannose suppresses HIF-1α mediated metabolic reprogramming in clear cell renal cell carcinoma

  2025cites this paper
• Clinical Implications of Hypoxia-Inducible Factor-1α Expression in Bladder Cancer

  2025cites this paper
• Exploratory Advanced Radiotherapies for Ameloblastoma and Ameloblastic Carcinoma—A Concise Review

  2025cites this paper
• Mid-treatment changes in intra-tumoural metabolic heterogeneity correlate to outcomes in oropharyngeal squamous cell carcinoma patients

  2025cites this paper
• Influence of Hypoxia on Tumor Heterogeneity, DNA Repair, and Cancer Therapy: From Molecular Insights to Therapeutic Strategies

  2025cites this paper
• Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy.

  2025cites this paper
• A prognostic model for head and neck squamous cell carcinoma based on radiotherapy sensitivity insights from nasopharyngeal carcinoma

  2025cites this paper
• Mitochondria-targeting of oxidative phosphorylation inhibitors to alleviate hypoxia and enhance anticancer treatment efficacy.

  2025cites this paper
• Copper-Induced Cuproptosis and Immunogenic Cell Death Synergize with Radiotherapy and PD-1 Blockade in Osteosarcoma.

  2025cites this paper
• Current and future therapies for small cell lung carcinoma

  2025cites this paper
• The role of mitochondria in metastasis development.

  2024cites this paper
• Cancer as a global health crisis with deep evolutionary roots

  2024cites this paper
• Molecular changes in breast cancer induced by radiation therapy.

  2024cites this paper
• Role of HIF-1α in the Responses of Tumors to Radiotherapy and Chemotherapy

  2024influential citation
• Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models

  2024cites this paper
• Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment

  2024cites this paper
• Microbiome's Universe: Impact on health, disease and cancer treatment.

  2024cites this paper
• YAP1 Overexpression Enhances the Aerobic Glycolysis Process via Suppression of EGLN2 in Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• A thermo-sensitive hydrogel with prominent hemostatic effect prevents tumor recurrence via anti-anoikis-resistance

  2024cites this paper
• Radiotherapy induces an increase in serum antioxidant capacity reflecting tumor response

  2024cites this paper
• PPARα Agonism Enhances Immune Response to Radiotherapy While Dietary Oleic Acid Results in Counteraction

  2024cites this paper
• The promising role of miRNAs in radioresistance and chemoresistance of nasopharyngeal carcinoma

  2024cites this paper
• Preoperative prognostic prediction for invasive pulmonary adenocarcinoma: Impact of 18F-FDG PET/CT semi-quantitative parameters associated with new histological subtype classification.

  2024cites this paper
• Morphological and Molecular Biological Characteristics of Experimental Rat Glioblastoma Tissue Strains Induced by Different Carcinogenic Chemicals

  2024cites this paper
• A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation

  2024cites this paper
• The potential of targeted radionuclide therapy to treat hypoxic tumor cells.

  2024cites this paper
• MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells.

  2024cites this paper
• The effect of baseline O2 conditions on the response of prostate cancer cells to hypoxia.

  2024cites this paper
• Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocarcinoma cells under glucose-deprived conditions.

  2024cites this paper
• Effects of intensity-modulated radiotherapy combined with chemotherapy and prognostic factors in patients with locally advanced oesophageal cancer.

  2024cites this paper
• Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review

  2024cites this paper
• Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: A systematic review and single-arm meta-analysis.

  2024cites this paper
• Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation

  2023cites this paper
• Hypoxia A Typical Target in Human Lung Cancer Therapy.

  2023cites this paper
• Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.

  2023cites this paper
• A review on reactive oxygen species (ROS)-inducing nanoparticles activated by uni- or multi-modal dynamic treatment for oncotherapy.

  2023cites this paper
• Manganese facilitated cGAS-STING-IFNI pathway activation induced by ionizing radiation in glioma cells

  2023cites this paper
• Neodymium and manganese ions co-doped whitlockite for temperature monitoring, photothermal therapy, and bone tissue repair in osteosarcoma.

  2023cites this paper
• The role of tumor microenvironment on cancer stem cell fate in solid tumors

  2023cites this paper
• Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665/NOTCH1 axis

  2023cites this paper
• Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1

  2023cites this paper
• NPAS2 promotes aerobic glycolysis and tumor growth in prostate cancer through HIF-1A signaling

  2023cites this paper
• Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer

  2023cites this paper
• Metabolic factors associated with the prognosis of oligometastatic patients treated with stereotactic body radiotherapy

  2023cites this paper
• Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models

  2023cites this paper
• PI3K/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer

  2023cites this paper
• Emerging Plasmonic Nanoparticles and Their Assemblies for Cancer Radiotherapy.

  2023cites this paper
• Application of individualized multimodal radiotherapy combined with immunotherapy in metastatic tumors

  2023cites this paper
• [18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription.

  2023cites this paper
• A powerful antitumor "trident": the combination of radio-, immuno- and anti-angiogenesis therapy based on mesoporous silica single coated gold nanoparticles.

  2023cites this paper
• Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes

  2023cites this paper
• MicroRNA-17-5p and MicroRNA-130b-3p Promote Radioresistance of Glioma Stem Cells by Targeting PTEN/AKT/HIF-1α Pathway-Controlled Phosphopentose Metabolism

  2023cites this paper
• Metal-Organic Framework-Derived Multifunctional Nucleic Acid Nanoprobes for Hypoxia Imaging-Guided Radiosensitization.

  2023cites this paper
• Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer

  2023influential citation
• Engineering Semicarbazide‐Bearing Polypeptide Conjugates for Efficient Tumor Chemotherapy and Imaging of Tumor Metastasis

  2023cites this paper
• Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology

  2022cites this paper
• Inhibition of hypoxia-inducible factor 1 by acriflavine renders glioblastoma sensitive for photodynamic therapy.

  2022cites this paper
• Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)

  2022cites this paper
• The metabolic addiction of cancer stem cells

  2022cites this paper
• HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR)

  2022cites this paper
• Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway

  2022cites this paper
• Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1 α Pathway

  2022cites this paper
• HIF-1α Mediates Arsenic-Induced Metabolic Reprogramming in Lung Bronchial Epithelial Cells

  2022cites this paper
• Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation

  2022cites this paper
• Application of two-dimensional difference gel electrophoresis to identify protein changes between center, margin, and adjacent non-tumor tissues obtained from non-small-cell lung cancer with adenocarcinoma or squamous cell carcinoma subtype

  2022cites this paper
• Assessment of Serum Hypoxia Biomarkers Pre- and Post-radiotherapy in Patients with Brain Tumors

  2022cites this paper
• AKT, a Key Transmitter of HIF-1α and AR Signaling Pathways, Has a Critical Role in the Apigetrin-Mediated Anti-Cancer Effects in Prostate Cancer Cells

  2022cites this paper
• Recent progresses on radiotherapeutics-based treatment of cancer with two-dimensional nanomaterials

  2022cites this paper
• Hypoxia responsive and tumor-targeted mixed micelles for enhanced cancer therapy and real-time imaging.

  2022cites this paper
• Noncoding RNAs in the Glycolysis of Ovarian Cancer

  2022cites this paper
• Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy.

  2022cites this paper
• A nitric oxide and hydrogen sulfide dual-donating nanosystem for highly synergistic gas-radiotherapy against hepatocellular carcinoma.

  2022cites this paper
• Tumor acidity/redox hierarchical-activable nanoparticles for precise combination of X-ray-induced photodynamic therapy and hypoxia-activated chemotherapy.

  2022cites this paper
• Long-Term Cardiac Damage Associated With Abdominal Irradiation in Mice

  2022cites this paper
• The Lymphatic Endothelium in the Context of Radioimmuno-Oncology

  2022cites this paper
• CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation

  2022cites this paper
• Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment

  2022cites this paper
• BTN3A1 promotes tumor progression and radiation resistance in esophageal squamous cell carcinoma by regulating ULK1-mediated autophagy

  2022cites this paper
• Efficacy and Safety of Daprodustat Vs rhEPO for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis

  2022cites this paper
• Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of Glioblastoma

  2022cites this paper
• Combined biological effects and lung proteomics analysis in mice reveal different toxic impacts of electronic cigarette aerosol and combustible cigarette smoke on the respiratory system

  2022cites this paper
• Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy

  2022cites this paper
• Recent advances in radiosensitivity determinants in melanoma

  2022cites this paper
• Cassiaside C Inhibits M1 Polarization of Macrophages by Downregulating Glycolysis

  2022influential citation
• MOLECULAR MECHANISMS UNDERLYING CANCER CELL RADIORESISTANCE

  2022cites this paper
• Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1α and promotes cervical cancer progression.

  2022cites this paper
• FSH mediates estradiol synthesis in hypoxic granulosa cells by activating glycolytic metabolism through the HIF-1α–AMPK–GLUT1 signaling pathway

  2022cites this paper
• Targeted Drug/Gene/Photodynamic Therapy via a Stimuli‐Responsive Dendritic‐Polymer‐Based Nanococktail for Treatment of EGFR‐TKI‐Resistant Non‐Small‐Cell Lung Cancer

  2022cites this paper
• Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer

  2021cites this paper
• Targeting Oxidative Phosphorylation to Increase the Efficacy of Radio- and Immune-Combination Therapy

  2021cites this paper
• “Suffocating” tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy

  2021cites this paper
• Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha

  2021cites this paper
• Dual-mode endogenous and exogenous sensitization of tumor radiotherapy through antifouling dendrimer-entrapped gold nanoparticles

  2021cites this paper